Patents by Inventor Laura Pilar RODRIGUEZ PASCAU

Laura Pilar RODRIGUEZ PASCAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957670
    Abstract: The present disclosure relates to a method of treating or preventing mitochondrial diseases by administering 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione or a salt thereof to a subject in need thereof. The disclosure also relates to 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione for use in a pharmaceutical composition or in the manufacture of a medicament for the treatment or prevention of a mitochondrial disease.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: April 16, 2024
    Assignee: Minoryx Therapeutics S.L.
    Inventors: Marc Martinell Pedemonte, Maria Pilar Pizcueta Lalanza, Laura Pilar Rodríguez Pascau
  • Patent number: 11440898
    Abstract: The application is directed to compounds of formula (I):(I), and formula (IA):(IA) and their salts and solvates, wherein R1, R2, R3, R4, R5, n, A1, A2, A3, and Y are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of conditions associated with the alteration of the activity of ?-galactosidase, specially galactosidase beta-1 or GLB 1, including GM 1 gangliosidoses and Morquio syndrome, type B.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: September 13, 2022
    Assignee: Minoryx Therapeutics S.L.
    Inventors: Ana Maria García Collazo, Marc Martinell Pedemonte, Elena Cubero Jordà, Xavier Barril Alonso, Laura Pilar Rodriguez Pascau
  • Publication number: 20210228559
    Abstract: The present disclosure relates to a method of treating or preventing mitochondrial diseases by administering 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione or a salt thereof to a subject in need thereof. The disclosure also relates to 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione for use in a pharmaceutical composition or in the manufacture of a medicament for the treatment or prevention of a mitochondrial disease.
    Type: Application
    Filed: June 6, 2019
    Publication date: July 29, 2021
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Marc MARTINELL PEDEMONTE, Maria Pilar PIZCUETA LALANZA, Laura Pilar RODRÍGUEZ PASCAU
  • Publication number: 20200071294
    Abstract: The application is directed to compounds of formula (I):(I), and formula (IA):(IA) and their salts and solvates, wherein R1, R2, R3, R4, R5, n, A1, A2, A3, and Y are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of conditions associated with the alteration of the activity of ?-galactosidase, specially galactosidase beta-1 or GLB 1, including GM 1 gangliosidoses and Morquio syndrome, type B.
    Type: Application
    Filed: December 27, 2017
    Publication date: March 5, 2020
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Ana Maria GARCÍA COLLAZO, Marc MARTINELL PEDEMONTE, Elena CUBERO JORDÀ, Xavier BARRIL ALONSO, Laura Pilar RODRIGUEZ PASCAU